Medical licensing and credentialing platform Medallion raised $43 million in a new funding round led by Acrew Capital. The round, which brings Medallion's total raise to $130 million, included ...

ArteraAI Prostate uses digital pathology images from a patient’s biopsy to predict potential long-term outcomes of their prostate cancer.

The companies will develop AI models trained on real-world data to help identify and diagnose patients with paroxysmal nocturnal hemoglobinuria.

ArteraAI Prostate forecasts potential long-term outcomes of a patient's prostate cancer biopsy slide based on digital pathology images.

The financing comes on top of the company's $900 million annual research and development investment in the U.S.

The company's CEO defended its feature as a wellness tool under the 21st Century Cures Act, combatting the FDA’s claim that it qualifies as a regulated medical device.

The alliance aims to benefit patients with chronic conditions and allow real-time interoperability among healthcare providers, pharmacies and payers.

Brain health and dementia care platform Isaac Health has secured $10.5 million in Series A funding, bringing its total raise ...

Data from Dexcom CGMs will be integrated into FriskaAi and will be monitored by AI-powered algorithms that alerts patients when action is advised.

Maven Clinic introduces male fertility support tools, Scripta Insights announces a tool to locate cost-effective meds, and ...